Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 8,522 | 86,276 | 10,013 | 8,921 | 2,207 |
| Operating Income | -8,522 | -86,276 | -10,013 | -8,921 | -2,207 |
| Other Income | 634 | 290 | -72 | -9,601 | -12 |
| Pre-tax Income | -7,888 | -85,986 | -10,085 | -18,522 | -2,218 |
| Net Income Continuous | -7,952 | -85,986 | -10,085 | -18,522 | -2,218 |
| Net Income | $-7,952 | $-85,986 | $-10,085 | $-18,522 | $-2,218 |
| EPS Basic Total Ops | -65.67 | -510.19 | -71.96 | -200.90 | -35.98 |
| EPS Basic Continuous Ops | -67.44 | -510.15 | -71.24 | -199.79 | -37.80 |
| EPS Diluted Total Ops | -65.67 | -510.19 | -71.96 | -200.90 | -35.98 |
| EPS Diluted Continuous Ops | -67.44 | -510.15 | -71.24 | -199.79 | -37.80 |
| EBITDA(a) | $-8,399 | $-86,152 | $-9,896 | $-8,826 | $-2,182 |